Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do some antiphospholipid antibodies target endothelial cells?

M Dueymes1, Y Levy, L Ziporen

  • 1Laboratoire d'Immunologie, CHU, Brest, France.

Annales De Medecine Interne
|September 1, 1996
PubMed
Summary

Antiphospholipid antibodies (aPLA) target endothelial cells (EC) in connective tissue diseases. This interaction is mediated by beta-2-glycoprotein I (beta 2-GPI), which is crucial for aPLA binding to EC.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Within patient horizontal gene transfer dynamics of a bla<sub>NDM-7</sub> plasmid among four different bacterial species.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2025
Same author

[The MASK lift].

Annales de chirurgie plastique et esthetique·2024
Same author

Role of the environment in transmission of Gram-negative bacteria in two consecutive outbreaks in a haematology-oncology department.

Infection prevention in practice·2022
Same author

Epidemiological, clinical, and echocardiographic features, and outcome of dogs with Ebstein's anomaly: 32 cases (2002-2016).

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2020
Same author

Assessment of bovine tuberculosis surveillance effectiveness in French wildlife: An operational approach.

Preventive veterinary medicine·2020
Same author

[Is AMH a fertility marker?]

Gynecologie, obstetrique, fertilite & senologie·2019

Area of Science:

  • Immunology
  • Vascular Biology
  • Rheumatology

Background:

  • Antiphospholipid antibodies (aPLA) are implicated in thrombotic events and pregnancy complications.
  • Endothelial cells (EC) play a critical role in vascular homeostasis and inflammation.
  • The precise mechanisms by which aPLA interact with EC are not fully elucidated.

Purpose of the Study:

  • To investigate the role of antiphospholipid antibodies (aPLA) in anti-endothelial cell (EC) activity.
  • To determine the involvement of beta-2-glycoprotein I (beta 2-GPI) in the binding of aPLA to EC.
  • To understand how anti-EC antibodies influence the expression of phospholipids on EC.

Main Methods:

  • Detection of aPLA and anti-EC antibodies in patients with connective tissue diseases.

Related Experiment Videos

  • Assessment of cardiolipin-binding monoclonal antibodies' recognition of EC.
  • Evaluation of anionic phospholipid expression on the EC membrane.
  • Analysis of anti-beta 2-glycoprotein I (beta 2-GPI) monoclonal antibody binding to EC.
  • Investigation of aPLA binding to EC in the presence and absence of beta 2-GPI.

    • Main Results:

    • Cardiolipin-binding monoclonal antibodies were found to recognize EC.
    • Anionic phospholipids are present on the outer surface of the EC membrane.
    • An anti-beta 2-GPI monoclonal antibody demonstrated binding to EC.
    • The binding of aPLA to EC and its functional affinity are dependent on the presence of beta 2-GPI.
    • Anti-EC antibodies were observed to induce the expression of anionic phospholipids on the EC membrane.

    Conclusions:

    • Antiphospholipid antibodies (aPLA) contribute to anti-endothelial cell (EC) activity.
    • Beta-2-glycoprotein I (beta 2-GPI) is essential for the binding of aPLA to EC.
    • The interaction between aPLA, beta 2-GPI, and EC may play a role in the pathogenesis of conditions associated with antiphospholipid syndrome.